Cromolyn Sodium (Bausch & Lomb Incorporated)
Welcome to the PulseAid listing for the Cromolyn Sodium drug offered from Bausch & Lomb Incorporated. This Decreased Histamine Release [PE],Mast Cell Stabilizer [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Bausch & Lomb Incorporated |
| NON-PROPRIETARY NAME: | cromolyn sodium |
| SUBSTANCE NAME: | CROMOLYN SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Histamine Release [PE],Mast Cell Stabilizer [EPC] |
| ROUTE: | OPHTHALMIC |
| DOSAGE FORM: | SOLUTION/ DROPS |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 1995-01-30 |
| END MARKETING DATE: | 0000-00-00 |
Cromolyn Sodium HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cromolyn Sodium from Bausch & Lomb Incorporated |
| LABELER NAME: | Bausch & Lomb Incorporated |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 40(mg/mL) |
| START MARKETING DATE: | 1995-01-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 24208-961_3fc807e4-d67b-46dd-8fb6-4f00fb6906d7 |
| PRODUCT NDC: | 24208-961 |
| APPLICATION NUMBER: | ANDA074443 |
Other CROMOLYN SODIUM Pharmaceutical Manufacturers / Labelers:
